Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02723617 · ClinicalTrials.gov registry record · NA

The Dose-Response Effects of Lean Beef in a Mediterranean-Style Dietary Pattern on Cardiovascular Disease Risk Factors

A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT02723617: Completed NA study, sponsored by USDA Beltsville Human Nutrition Research Center.

NCT02723617 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02723617, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the effects of different quantities of lean beef (0.5, 2.5, 5.5 oz/day) on lipids, lipoproteins, and vascular health endpoints in the context of a modified Mediterranean dietary pattern that is representative of foods typically consumed in the United States.

Primary Outcome

The following will be measured in the blood on 2 consecutive days at baseline (start of trial) and the end of each 4-week diet period: lipids and lipoproteins, apolipoproteins, lipoprotein particle number/size, and proprotein convertase subtilisin/kexin type 9 (PCSK9).

Interventions

  • OTHER MED 0.5
  • OTHER MED 2.5
  • OTHER MED 5.5
  • OTHER AAD 2.5

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2016-04-25
Est. Completion 2018-05-16
Phase NA

What the finished NCT02723617 record still lists

NCT02723617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 4 interventions - of which MED 0.5 is the first listed.

NCT02723617 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02723617 about?

NCT02723617 is a clinical study titled "The Dose-Response Effects of Lean Beef in a Mediterranean-Style Dietary Pattern on Cardiovascular Disease Risk Factors". The objective of this study is to evaluate the effects of different quantities of lean beef (0.5, 2.5, 5.5 oz/day) on lipids, lipoproteins, and vascular health endpoints in the context of a modified Mediterranean dietary pattern that is representative of foods typically consumed in the United States...

What is the current status of trial NCT02723617?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2016-04-25. Estimated completion is 2018-05-16.

What interventions are being tested in trial NCT02723617?

The interventions under investigation include: MED 0.5 (OTHER), MED 2.5 (OTHER), MED 5.5 (OTHER), AAD 2.5 (OTHER).

Who is sponsoring clinical trial NCT02723617?

This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02723617's enrollment target sits among peer trials

66 1139th of 2000 higher than 857 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02723617, the US trial registry maintained by the National Library of Medicine. NCT02723617 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.